Israeli life sciences firms’ capital-raising slows 40% in first half of 2023

Local life sciences firms turn to US stock markets for funding; private foreign investors’ activity more than halves, data by the Israel Advanced Technology Industries shows…
Read More

About The Author

Jonathan Jeriah

See author's posts